Gene · 9075
Papers2,543
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,543
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-10b-5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes. | United European Gastroenterol J | 2023 | 37723933 | PubTator, text mining | PubMed |
| Alpha-tocopherylquinone-mediated activation of the Aryl Hydrocarbon Receptor regulates the production of inflammation-inducing cytokines and ameliorates intestinal inflammation. | Mucosal Immunol | 2023 | 37716509 | PubTator, text mining | PubMed |
| Cannabinoid receptor type 1 in the aging gut regulates the mucosal permeability via miR-191-5p. | Front Endocrinol (Lausanne) | 2023 | 37693348 | PubTator, text mining | PubMed |
| Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease. | EMBO Rep | 2023 | 37691494 | PubTator, text mining | PubMed |
| Aberrant Expression of Claudins in Head and Neck Carcinomas and Their Prognostic and Therapeutic Value: A Narrative Review. | Cancers (Basel) | 2023 | 37686483 | PubTator, text mining | PubMed |
| miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis. | Cells | 2023 | 37681916 | PubTator, text mining | PubMed |
| Update and latest advances in mechanisms and management of colitis-associated colorectal cancer. | World J Gastrointest Oncol | 2023 | 37663937 | PubTator, text mining | PubMed |
| Incidence, prevalence, and comorbidities of chronic pancreatitis: A 7-year population-based study. | World J Gastroenterol | 2023 | 37662860 | PubTator, text mining | PubMed |
| β(2 → 1)-β(2 → 6) and β(2 → 1) fructans protect from impairment of intestinal tight junction's gene expression and attenuate human dendritic cell responses in a fructan-dependent fashion. | Carbohydr Polym | 2023 | 37659831 | PubTator, text mining | PubMed |
| Sinapic acid alleviates inflammatory bowel disease (IBD) through localization of tight junction proteins by direct binding to TAK1 and improves intestinal microbiota. | Front Pharmacol | 2023 | 37649894 | PubTator, text mining | PubMed |
| Th22 cells and the intestinal mucosal barrier. | Front Immunol | 2023 | 37646028 | PubTator, text mining | PubMed |
| Sucrose-induced hyperglycemia dysregulates intestinal zinc metabolism and integrity: risk factors for chronic diseases. | Front Nutr | 2023 | 37637953 | PubTator, text mining | PubMed |
| Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned. | Diagnostics (Basel) | 2023 | 37627923 | PubTator, text mining | PubMed |
| Expression of Claudins in Preneoplastic Conditions of the Gastrointestinal Tract: A Review. | Cancers (Basel) | 2023 | 37627123 | PubTator, text mining | PubMed |
| Sex disparities in non-small cell lung cancer: mechanistic insights from a cRaf transgenic disease model. | EBioMedicine | 2023 | 37625265 | PubTator, text mining | PubMed |
| Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma. | Pathol Oncol Res | 2023 | 37621953 | PubTator, text mining | PubMed |
| Induction of open-form bile canaliculus formation by hepatocytes for evaluation of biliary drug excretion. | Commun Biol | 2023 | 37608051 | PubTator, text mining | PubMed |
| Potential Ability of Probiotics in the Prevention and Treatment of Colorectal Cancer. | Clin Med Insights Oncol | 2023 | 37601319 | PubTator, text mining | PubMed |
| Maternal Epidermal Growth Factor Promotes Neonatal Claudin-2 Dependent Increases in Small Intestinal Calcium Permeability. | Function (Oxf) | 2023 | 37575484 | PubTator, text mining | PubMed |
| Targeted Application of Functional Foods as Immune Fitness Boosters in the Defense against Viral Infection. | Nutrients | 2023 | 37571308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9075/papers?page=14